Bidirectional induction of the cognate receptor-ligand alpha4/VCAM-1 pair defines a novel mechanism of tumor intravasation.
Engagement of cell surface adhesion receptors with extracellular constituents and with cellular counter-receptors is crucial for the extravasation of blood-borne neoplastic cells and their seeding at distant sites; however, the early events of tumor dissemination-ie, the intravasation step(s)-have been largely neglected. A role for the alpha4beta7 integrin was hypothesized to explain the high leukemogenicity exhibited by one (NQ22) among several T-cell lymphomas studied. To clarify the mechanisms of early aggressivity, the behavior of highly and poorly leukemogenic cell lines were compared in vitro. Cocultivation of physically separated leukemic cells with resting endothelial cells resulted in the up-regulation of VCAM-1 expression. NQ22 cells expressed mRNA of different cytokines that up-regulate VCAM-1 and at higher levels than cells of a nonaggressive lymphoma, and they migrated more efficiently through an activated endothelial cell layer. With the use of neutralizing antibodies against interferon-gamma, granulocyte macrophage colony-stimulating factor, and tumor necrosis factor (TNF)-alpha, it was determined that TNF-alpha is one of the soluble factors released by NQ22 cells involved in the up-regulation of VCAM-1. The finding that vascular cells within the early local growth were strongly positive for VCAM-1 indicated that NQ22 cells could activate endothelial cells also in vivo. Finally, cocultivation of preleukemic alpha4(-)NQ22 cells with TNF-alpha-activated endothelial cells induced the expression of alpha4 integrins on the former cells. Reciprocal up-regulation and engagement of alpha4/VCAM-1 pairs determined the sequential transmigration and intravasation steps, and similar mechanisms might affect the aggressivity of human T lymphoblastic lymphomas.
Bogetto
L
L
Divisione di Oncologia Sperimentale 2 and Divisione di Oncologia Sperimentale 1, CRO, Aviano, Italy.
Gabriele
E
E
Cariati
R
R
Dolcetti
R
R
Spessotto
P
P
Doglioni
C
C
Boiocchi
M
M
Perris
R
R
Colombatti
A
A
D000818:Animals; D000906:Antibodies; D002448:Cell Adhesion; D002465:Cell Movement; D018920:Coculture Techniques; D004730:Endothelium, Vascular / Q000502:physiology; D005260:Female; D005786:Gene Expression Regulation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000276:immunology / Q000502:physiology; D016023:Integrins / Q000235:genetics* / Q000502:physiology; D007371:Interferon-gamma / Q000276:immunology / Q000502:physiology; D016399:Lymphoma, T-Cell / Q000473:pathology*; D008297:Male; D051379:Mice; D008806:Mice, Inbred AKR; D009361:Neoplasm Invasiveness; D012333:RNA, Messenger / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000494:pharmacology / Q000502:physiology; D019010:Vascular Cell Adhesion Molecule-1 / Q000235:genetics* / Q000502:physiology
D000906:Antibodies; D016023:Integrins; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D019010:Vascular Cell Adhesion Molecule-1; C071777:integrin alpha4beta7; D007371:Interferon-gamma; D016178:Granulocyte-Macrophage Colony-Stimulating Factor